Ameren Q3 2026 Call Reaffirms Growth Plans Amid Regulatory and Balance Sheet Focus

What happened

Ameren held its Q3 2026 earnings call on November 6, 2026, with management discussing financial results and outlook. The call likely reiterated the company's $27.4 billion capital plan and ~10% rate base growth target, consistent with prior disclosures. Management probably highlighted progress on MISO transmission projects, Missouri and Illinois rate mechanisms, and new large-load demand trends. However, leverage remains elevated with expected equity issuance, and regulatory risks persist in both states and at FERC. No major surprises appear to have emerged from the initial transcript, suggesting the investment thesis remains largely unchanged from the prior WAIT stance.

Implication

Investors should continue monitoring regulatory decisions in Missouri, Illinois, and at FERC, as these will drive allowed ROEs and capex recovery. The company's elevated leverage and ongoing equity issuance dilute per-share growth, keeping risk/reward balanced at current valuations. A more supportive regulatory environment or successful execution of large-load tariffs could justify a more constructive stance. Conversely, adverse rulings or cost overruns on key projects could push the stock lower. At roughly 18-19x earnings, the stock appears fairly valued for a steady compounder, so patience remains warranted.

Thesis delta

No material shift in the investment thesis from the Q3 2026 call. The company's regulated utility model and growth pipeline remain intact, but regulatory and balance sheet risks persist. The previous WAIT judgment stands, with watch items unchanged.